• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 AXIUM HELIX; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 AXIUM HELIX; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number QC-3-6-HELIX
Medical Device Problem Code Separation Failure (2547)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Continuation of d10: product id qc-1.5-2-helix (lot: 226008758); product type: ; implant date n/a; explant date n/a product id qc-1.5-2-helix (lot: 226008758); product type: ; implant date n/a; explant date n/a product id 105-5091-150 (lot: b429392); product type: ; implant date n/a; explant date n/a product id qc-2-4-3d (225769257); product type: ; implant date n/a; explant date n/a; medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Medtronic received a report that two axium coils were found stretched and another two axium coils would not detach.The patient was undergoing surgery for treatment of a saccular, unruptured aneurysm.The accessed vessel was the femoral artery.It was noted the patient's blood flow was normal and vessel tortuosity was normal.It was reported that axium coil (lot #226008758 and 226008758) was stretched and successfully implanted after replacement.It was reported for the echelon catheter the spring coil could not be delivered to the lesion, but the operation was successfully completed after replacement.It was reported that the axium coil (lot # 226235035 and 225769257) was difficult to detach and implanted smoothly after replacement.The reported device and any accessory devices were prepared as indicated in the instructions for use (ifu).No patient symptoms or further complications were reported as a result of this event.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Additional information received reported there were no issues found with the echelon catheter.There was resistance during delivery of qc-3-6-helix in the echelon catheter.Two attempts were made to detach the coil using the manual menthod.Prior to non-detachment adjusted the position of the coil multiple times in the aneurysm.
 
Additional Manufacturer Narrative
H3: the axium implant coil was found to be stretched and damaged within introducer sheath.No other anomalies were observed.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIUM HELIX
Common Device Name
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key19033993
Report Number9612164-2024-01583
Device Sequence Number17897478
Product Code KRD
UDI-Device Identifier00847536037366
UDI-Public00847536037366
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K081465
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 06/10/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/25/2026
Device Model NumberQC-3-6-HELIX
Device Catalogue NumberQC-3-6-HELIX
Device Lot Number226235035
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/01/2024
Supplement Date Received by Manufacturer04/08/2024
05/16/2024
Initial Report FDA Received Date04/03/2024
Supplement Report FDA Received Date04/30/2024
06/10/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/25/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-